TrialPsychopharmacology2015

Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).

Tsuyoshi Miyaoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.